Literature DB >> 25755789

Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection.

Jian Zheng1.   

Abstract

Cervical cancer remains the fourth most common cause of cancer-related deaths in women worldwide, and human papillomavirus infection represents the most important risk factor for the development of cervical cancer. Minichromosome maintenance protein-2 has been previously identified by DNA microarray and transcriptional profiling as genes that is overexpressed in cervical carcinomas. 183 cases were enrolled and tested with thin prep liquid-based cytology test. The expressions of human papillomavirus were detected and minichromosome maintenance protein-2 immuncytochemical test was performed on liquid-based pap smears from the samples. Those results were compared with the cervical histopathology results. The positive expression rates of minichromosome maintenance protein-2 and high-risk type human papillomavirus increased with the severity of cervical lesions. The expression level of MCM2 was positively correlated with high-risk types of human papillomavirus. In cervical carcinoma and precancerous lesions, minichromosome maintenance protein-2 was overexpressed and positively correlated with the high risk types of human papillomavirus. As minichromosome maintenance protein-2 immuncytochemical detection was better than genotyping of human papillomavirus, minichromosome maintenance protein-2 may serve as a useful marker in the screening of cervical carcinoma and precancerous lesions and improve the diagnosis of atypical squamous cell of undetermined significance. The joint application can improve the sensitivity and specificity of diagnosis.

Entities:  

Keywords:  Cervical lesions; human papillomavirus; immuncytochemical test; minichromosome maintenance protein-2

Mesh:

Substances:

Year:  2015        PMID: 25755789      PMCID: PMC4348922     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Improved cervical smear assessment using antibodies against proteins that regulate DNA replication.

Authors:  G H Williams; P Romanowski; L Morris; M Madine; A D Mills; K Stoeber; J Marr; R A Laskey; N Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 4.  MCM proteins: evolution, properties, and role in DNA replication.

Authors:  S E Kearsey; K Labib
Journal:  Biochim Biophys Acta       Date:  1998-06-16

5.  Identification of cervical cancer markers by cDNA and tissue microarrays.

Authors:  Yan Chen; Christine Miller; Rebecca Mosher; Xumei Zhao; Jim Deeds; Mike Morrissey; Barb Bryant; David Yang; Ron Meyer; Frank Cronin; Bobbie S Gostout; Karen Smith-McCune; Robert Schlegel
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

Review 6.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

7.  The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note.

Authors:  A L Herbst; K E Pickett; M Follen; K L Noller
Journal:  Obstet Gynecol       Date:  2001-11       Impact factor: 7.661

8.  Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

Authors:  Alessandro D Santin; Fenghuang Zhan; Eliana Bignotti; Eric R Siegel; Stefania Cané; Stefania Bellone; Michela Palmieri; Simone Anfossi; Maria Thomas; Alexander Burnett; Helen H Kay; Juan J Roman; Timothy J O'Brien; Erming Tian; Martin J Cannon; John Shaughnessy; Sergio Pecorelli
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

9.  Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray.

Authors:  Tae Sook Hwang; Jeongmi Kim Jeong; Misun Park; Hye Seung Han; Hyo Kyoung Choi; Tae Shin Park
Journal:  Gynecol Oncol       Date:  2003-07       Impact factor: 5.482

Review 10.  MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.

Authors:  Abraham Pedroza-Torres; Eduardo López-Urrutia; Verónica García-Castillo; Nadia Jacobo-Herrera; Luis A Herrera; Oscar Peralta-Zaragoza; César López-Camarillo; David Cantú De Leon; Jorge Fernández-Retana; Jorge F Cerna-Cortés; Carlos Pérez-Plasencia
Journal:  Molecules       Date:  2014-05-16       Impact factor: 4.411

View more
  11 in total

1.  Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Authors:  Emmanouil Papasavvas; Andrew V Kossenkov; Livio Azzoni; Nicola M Zetola; Agnieszka Mackiewicz; Brian N Ross; Matthew Fair; Surya Vadrevu; Doreen Ramogola-Masire; Ian Sanne; Cynthia Firnhaber; Luis J Montaner
Journal:  Carcinogenesis       Date:  2019-04-29       Impact factor: 4.944

2.  MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2.

Authors:  Xiurong Lu; Xiao Song; Xiaohui Hao; Xiaoyu Liu; Xianyu Zhang; Na Yuan; Huan Ma; Zhilin Zhang
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

3.  An interaction network driven approach for identifying biomarkers for progressing cervical intraepithelial neoplasia.

Authors:  Shikha Suman; Ashutosh Mishra
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

4.  Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy.

Authors:  Xin Tang; Yicong Xu; Lin Lu; Yang Jiao; Jianjun Liu; Linlin Wang; Hongbo Zhao
Journal:  Cancer Manag Res       Date:  2018-09-13       Impact factor: 3.989

Review 5.  Progress in immunocytochemical staining for cervical cancer screening.

Authors:  Hengzi Sun; Keng Shen; Dongyan Cao
Journal:  Cancer Manag Res       Date:  2019-02-22       Impact factor: 3.989

6.  MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer.

Authors:  Yajun Deng; Hanyun Ma; Jinyong Hao; Qiqi Xie; Ruochen Zhao
Journal:  Biomed Res Int       Date:  2020-04-28       Impact factor: 3.411

7.  Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.

Authors:  Baojie Wu; Shuyi Xi
Journal:  BMC Cancer       Date:  2021-06-26       Impact factor: 4.430

8.  Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.

Authors:  Hua-Ju Yang; Jin-Min Xue; Jie Li; Ling-Hong Wan; Yu-Xi Zhu
Journal:  Mol Genet Genomic Med       Date:  2020-03-17       Impact factor: 2.183

9.  Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.

Authors:  Gurjeet Kaur; Shandra Devi Balasubramaniam; Yung Jen Lee; Venugopal Balakrishnan; Chern Ein Oon
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01

10.  Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.

Authors:  Hong-Yan Han; Jiang-Tao Mou; Wen-Ping Jiang; Xiu-Ming Zhai; Kun Deng
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.